MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

Search

Moderna Inc

Atvērts

SektorsVeselības aprūpe

53.15 11.73

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

47.18

Max

55.15

Galvenie mērījumi

By Trading Economics

Ienākumi

625M

-200M

Pārdošana

874M

1B

EPS

-0.51

Peļņas marža

-19.685

Darbinieki

5,800

EBITDA

625M

-135M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-30.4% downside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 13. febr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

6.6B

16B

Iepriekšējā atvēršanas cena

41.42

Iepriekšējā slēgšanas cena

53.15

Ziņu noskaņojums

By Acuity

17%

83%

31 / 360 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Moderna Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. jūn. 10:41 UTC

Galvenie tirgus virzītāji

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine

2025. g. 31. marts 14:19 UTC

Galvenie tirgus virzītāji

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

2025. g. 4. febr. 18:52 UTC

Galvenie tirgus virzītāji

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

2025. g. 6. nov. 16:16 UTC

Peļņas

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

2025. g. 6. nov. 12:29 UTC

Peļņas

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025. g. 6. nov. 12:15 UTC

Peļņas

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025. g. 1. okt. 20:20 UTC

Iegādes, apvienošanās, pārņemšana

These Stocks Moved the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More -- Barrons.com

2025. g. 10. jūn. 12:18 UTC

Peļņas

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. -- Barrons.com

2025. g. 27. maijs 17:59 UTC

Top Ziņas

Kennedy, Skipping Regulatory Steps, Limits Use of Covid-19 Shots -- Barrons.com

2025. g. 12. maijs 22:14 UTC

Top Ziņas

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

2025. g. 12. maijs 18:45 UTC

Top Ziņas

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

2025. g. 12. maijs 17:14 UTC

Top Ziņas

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- WSJ

2025. g. 28. apr. 17:04 UTC

Peļņas

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

2025. g. 28. febr. 12:00 UTC

Top Ziņas

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

2025. g. 24. febr. 10:17 UTC

Karstas akcijas

Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba -- WSJ

2025. g. 14. febr. 22:04 UTC

Peļņas

These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025. g. 14. febr. 20:26 UTC

Peļņas

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025. g. 14. febr. 17:34 UTC

Peļņas

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025. g. 14. febr. 15:42 UTC

Peļņas

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DraftKings, GameStop, and More -- Barrons.com

2025. g. 14. febr. 14:02 UTC

Top Ziņas
Peļņas

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. -- Barrons.com

2025. g. 14. febr. 11:38 UTC

Top Ziņas
Peļņas

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

2025. g. 14. febr. 11:34 UTC

Peļņas

These Stocks Are Moving the Most Today: Intel, Airbnb, DraftKings, GameStop, Moderna, Roku, Palo Alto, and More -- Barrons.com

2025. g. 14. febr. 11:30 UTC

Top Ziņas
Peļņas

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

2025. g. 4. febr. 19:34 UTC

Top Ziņas

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

2025. g. 4. febr. 18:51 UTC

Top Ziņas

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Salīdzinājums

Cenas izmaiņa

Moderna Inc Prognoze

Cenas mērķis

By TipRanks

-30.4% uz leju

Prognoze 12 mēnešiem

Vidējais 29.93 USD  -30.4%

Augstākais 63 USD

Zemākais 17 USD

Pamatojoties uz 20 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Moderna Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

20 ratings

1

Pirkt

15

Turēt

4

Pārdot

Tehniskais rādītājs

By Trading Central

23.7 / 27.88Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

31 / 360 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat